[1] INGOLD I,BERNDT C,SCHMITT S,et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis [J]. Cell,2018,172(3):409-422.
[2] WAN S Y,ROHITHA S,MATTHEW E W,et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell,2014,156(1):317-331.
[3] LEE R C,FEINBAUM R L,AMBROS V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 [J]. Cell,2019,75(5):843-854.
[4] LV W Y,LI C H,LIN H R,et al. A high-integrated DNA biocomputing platform for MicroRNA sensing in living cells [J]. Biosens Bioelectron,2022,207(17):114183-114190.
[5] POTOCHI L,KARBARZ M,ADAMCZYK-GROCHALA J,et al. Silver birch pollen-derived microRNAs promote NF-κB-mediated inflammation in human lung cells[J]. Sci Total Environ,2021,800(15):149531-149539.
[6] WANG Z H,WANG D,GUO S,et al. Long noncoding RNA distal-less homeobox 2 antisense 1 restrains inflammatory response and apoptosis of periodontal ligament cells by binding with microRNA-330-3p to regulate Ro60,Y RNA binding protein[J]. Arch Oral Biol,2022,133(6): 105298-105303.
[7] LIU N,LIN X,HUANG C. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance [J]. Brit J Cancer,2019,122(2):1-14.
[8] SATO H,TAMBA M,ISHII T,et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins[J]. J Biol Chem,1999,274(7):11455-11458.
[9] CHAO L,GUO L,YANG N,et al. miR-324-3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma [J]. Cancer Cell Int,2017,17(1):1-7.
[10] HOU Y,CAI S,YU S,et al. Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer[J]. Acta Bioch Bioph Sin,2021,56(3):3-11.
[11] DENG S H,WU D M,LI L,et al. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549[J]. Biochem Bioph Res Co,2021,549(10):54-60.
[12] LI S,JIA H,ZHANG Z,et al. LncRNA GAS6-AS1 facilitates the progression of breast cancer by targeting the miR-324-3p/SETD1A axis to activate the PI3K/AKT pathway[J]. Eur J Cell Biol,2020,99(8):151124-151131.
[13] HUANG X H,WANG Q,CHEN J S,et al. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated [J]. Hepatol Res,2010,39(8):786-794.
[14] PENG Y,LIU Y M,LI L C,et al. MicroRNA-338 inhibits growth,invasion and metastasis of gastric cancer by targeting NRP1 expression [J]. PLoS One,2014,9(4):e94422-e94430.
[15] 张伟,彭燕琪,费思佳,等. miR-338通过靶向GPX4抑制非小细胞肺癌细胞增殖[J]. 现代肿瘤医学,2020,28(23): 4041-4045.
[16] CHEN J S,LIANG L L,XU H X,et al. MiR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells [J]. Oncotarget,2017,8(42):112-118.
[17] TARANGELO A,MAGTANONG L,BIEGING-ROLETT K T,et al. p53 suppresses metabolic stress-induced ferroptosis in cancer cells [J]. Cell Rep,2018,22(3):569-579.
[18] XIE Y,ZHU S,SONG X,et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity [J]. Cell Rep,2017,20(7):1692-1699.
[19] MAO C,WANG X,LIU Y,et al. A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53 [J]. Cancer Res,2018,56(112):3484-3490.
[20] SONG Z,JIA G,MA P,et al. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis[J]. Life Sci,2021,276(7689):119399-119406.
[21] KENNETH N,MUDIE S,NARON S,et al. TfR1 interacts with the IKK complex and is involved in IKK-NF-κB signaling [J]. Biochem J,2013,13(28):449-457.
[22] LU J,XU F,LU H. LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53[J]. Life Sci,2020,260(11):118305-118312.
[23] YANG Y R,ZANG S Z,ZHONG C L,et al. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer [J]. Int J Clin Exp Patho,2014,7(10):6929-6935.
[24] LI Y,ZHANG J,PAN S,et al. CircRNA CDR1 as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis[J]. Thorac Cancer,2020,11(3):112-120.
[25] BAI T,LIANG R,ZHU R,et al. MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells[J]. J Cell Physiol,2020(11):342-352.
[26] LE J,NING K,LI T,et al. Ferroptosis as a p53-mediated activity during tumour suppression [J]. Nature,2019,(18):262-270.
[27] YANG X,ZHANG Y,FAN H. Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1[J]. Cancer Gene Ther,2020,(45):23-33.
[28] KIRILL B,JOSEPH MH,LI Z,et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis[J]. Nature,2019,575(21):688-692.
[29] WU M,ZHANG X,ZHANG W,et al. Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis [J]. Nat Commun,2022,13(16):1371-1381.
[30] SONG X,LIU J,KUANG F,et al. PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis [J]. Cell Rep,2021,34(8): 108767-108775.
[31] HONG T,LEI G,CHEN X,et al. PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer [J]. Chem Biol Interact,2022,352(2):101928-101936.
[32] LI H,LIU L. Zinc moderates circular RNA CircFOXP1 expression in order to regulate ferroptosis during lung adenocarcinoma[J]. Redox Biol,2021,42(11):109760-109768.
[33] KUGANESAN N,DIAMINI S,TILLEKERATNE L M,et al. Tumor suppressor p53 promotes ferroptosis in oxidative stress conditions independent of modulation of ferroptosis by p21,CDKs,RB,and E2F[J]. J Biol Chem,2021,297(6):101365-101374.
[1]仝颖娜,刘晓彬,张露方,等.血胱抑素C等对肺癌患者化疗过程中肾损伤的评价[J].天津医科大学学报,2017,23(02):143.
TONG Ying-na,LIU Xiao-bin,ZHANG Lu-fang,et al.Evaluation of serum cystatin C in kidney function damage for patients with lung cancer during chemotherapy[J].Journal of Tianjin Medical University,2017,23(05):143.
[2]陈鸿运,李晓明,黄国胜,等.LncRNA PTCSC3过表达诱导非小细胞肺癌A549凋亡和氧化损伤并抑制细胞增殖和迁移[J].天津医科大学学报,2021,27(05):467.
CHEN Hong-yun,LI Xiao-ming,HUANG Guo-sheng,et al.Overexpression of LncRNA PTCSC3 induces apoptosis and oxidative damage of non-small cell lung cancer A549 and inhibits their proliferation and migration[J].Journal of Tianjin Medical University,2021,27(05):467.
[3]何磊,杜佳辉,李娜.miR-152通过靶向FGF2抑制肺癌A549细胞系的增殖侵袭[J].天津医科大学学报,2022,28(02):145.
HE Lei,DU Jia-hui,LI Na.The effect of miR-152 on the proliferation and invasion of lung cancer A549 cell line regulated by FGF2[J].Journal of Tianjin Medical University,2022,28(05):145.
[4]李洋 综述,郭锋杰,孟旭英,等.树突状细胞外泌体与肺癌免疫治疗[J].天津医科大学学报,2023,29(01):94.
[5]张思培,陈丽娟,秦建文,等.肺腺癌合并活动性肺结核患者用药讨论1例[J].天津医科大学学报,2023,29(04):440.
[6]杨秋慧,郝名英,刘思琪,等.Erastin和BIBR1532联合应用对胃癌细胞增殖的影响[J].天津医科大学学报,2023,29(06):575.
YANG Qiu-hui,HAO Ming-ying,LIU Si-qi,et al.Effects of the combination of Erastin and BIBR1532 on the proliferation of gastric cancer cells[J].Journal of Tianjin Medical University,2023,29(05):575.
[7]刘思琪,郝名英,黄欣宇,等.端粒酶TERT通过向线粒体转位抵抗胃癌细胞铁死亡的发生机制[J].天津医科大学学报,2024,30(02):110.[doi:10.20135/j.issn.1006-8147.2024.02.0110]
LIU Siqi,HAO Mingying,HUANG Xinyu,et al.The mechanism of telomerase TERT resisting ferroptosis in gastric cancer cells by translocating to mitochondria[J].Journal of Tianjin Medical University,2024,30(05):110.[doi:10.20135/j.issn.1006-8147.2024.02.0110]
[8]郝名英,刘思琪,黄欣宇,等.Erastin对骨肉瘤细胞生长及增殖的影响[J].天津医科大学学报,2024,30(03):193.[doi:10.20135/j.issn.1006-8147.2024.03.0193]
HAO Mingying,LIU Siqi,HUANG Xinyu,et al.Effects of erastin on the growth and proliferation of osteosarcoma cells[J].Journal of Tianjin Medical University,2024,30(05):193.[doi:10.20135/j.issn.1006-8147.2024.03.0193]
[9]曾晓娇,田玲,张景云.基于铁死亡通路的高糖诱导人肾小管上皮细胞损伤的机制研究[J].天津医科大学学报,2024,30(03):239.[doi:10.20135/j.issn.1006-8147.2024.03.0239]
ZENG Xiaojiao,TIAN Ling,ZHANG Jingyun.Exploring the mechanism of high glucose-induced injury in human renal tubular epithelial cells based on the ferroptosis pathway[J].Journal of Tianjin Medical University,2024,30(05):239.[doi:10.20135/j.issn.1006-8147.2024.03.0239]
[10]缪道玉,于方海 综述,张西波 审校.调节性细胞死亡方式参与阻塞性黄疸引起肝细胞损伤的机制研究[J].天津医科大学学报,2024,30(04):377.[doi:10.20135/j.issn.1006-8147.2024.04.0377]